Recent Posts

EXPOSURE TO POLYBROMINATED DIPHENYL ETHERS ASSOCIATES WITH HYPOTHYROIDISM

EXPOSURE TO  POLYBROMINATED DIPHENYL ETHERS  ASSOCIATES WITH HYPOTHYROIDISM Oulhote Y1, Chevrier J1, Bouchard MF Exposure to Polybrominated Diphenyl Ethers (PBDEs) and Hypothyroidism in Canadian Women. J Clin Endocrinol Metab. 2016 Feb;101(2):590-8. doi: 10.1210/jc.2015-2659. Epub 2015 Nov 25. Polybrominated diphenyl ethers (PBDEs) are used as flame retardants in a wide range of products, resulting in widespread […]

Read more »

Organ specificity in autoimmune diseases: thyroid and islet autoimmunity in alopecia areata

.Noso S1, Park C, Babaya N, Hiromine Y, Harada T, Ito H, Taketomo Y, Kanto K, Oiso N, Kawada A, Suzuki T, Kawabata Y, Ikegami H. J Clin Endocrinol Metab. 2015 May;100(5):1976-83 Although alopecia areata (AA) is one of the most frequent organ-specific autoimmune diseases, the association of AA with other autoimmune diseases and the […]

Read more »

Induction of painless thyroiditis in patients receiving programmed death 1 receptor immunotherapy for metastatic malignancies

Induction of painless thyroiditis in patients receiving programmed death 1 receptor immunotherapy for metastatic malignancies Orlov S1, Salari F, Kashat L, Walfish PG. . J Clin Endocrinol Metab. 2015 May;100(5):1738-41 Immunotherapies against immune checkpoints that inhibit T cell activation [cytotoxic T lymphocyte antigen 4 (CTLA-4) and programmed cell death 1 (PD-1)] are emerging and promising […]

Read more »

RAI IMPROVES OUTCOME IN INTERMEDIATE RISK THYROID CANCER

Adjuvant radioactive iodine therapy is associated with improved survival for patients with intermediate-risk papillary thyroid cancer.Ruel E1, Thomas S, Dinan M, Perkins JM, Roman SA, Sosa JA. J Clin Endocrinol Metab. 2015 Apr;100(4):1529-36 Papillary thyroid cancer (PTC) is the most common endocrine malignancy. The long-term prognosis is generally excellent. Due to a paucity of data, […]

Read more »

MORE ON PROPHYLACTIC CENTRAL NODE DISSECTION

Prophylactic central compartment lymph node dissection in papillary thyroid carcinoma: clinical implications derived from the first prospective randomized controlled single institution study.Viola D1, Materazzi G, Valerio L, Molinaro E, Agate L, Faviana P, Seccia V, Sensi E, Romei C, Piaggi P, Torregrossa L, Sellari-Franceschini S, Basolo F, Vitti P, Elisei R, Miccoli P. J Clin […]

Read more »

Recent Posts

EXPOSURE TO POLYBROMINATED DIPHENYL ETHERS ASSOCIATES WITH HYPOTHYROIDISM

EXPOSURE TO  POLYBROMINATED DIPHENYL ETHERS  ASSOCIATES WITH HYPOTHYROIDISM Oulhote Y1, Chevrier J1, Bouchard MF Exposure to Polybrominated Diphenyl Ethers (PBDEs) and Hypothyroidism in Canadian Women. J Clin Endocrinol Metab. 2016 Feb;101(2):590-8. doi: 10.1210/jc.2015-2659. Epub 2015 Nov 25. Polybrominated diphenyl ethers (PBDEs) are used as flame retardants in a wide range of products, resulting in widespread […]

Read more »

Organ specificity in autoimmune diseases: thyroid and islet autoimmunity in alopecia areata

.Noso S1, Park C, Babaya N, Hiromine Y, Harada T, Ito H, Taketomo Y, Kanto K, Oiso N, Kawada A, Suzuki T, Kawabata Y, Ikegami H. J Clin Endocrinol Metab. 2015 May;100(5):1976-83 Although alopecia areata (AA) is one of the most frequent organ-specific autoimmune diseases, the association of AA with other autoimmune diseases and the […]

Read more »

Induction of painless thyroiditis in patients receiving programmed death 1 receptor immunotherapy for metastatic malignancies

Induction of painless thyroiditis in patients receiving programmed death 1 receptor immunotherapy for metastatic malignancies Orlov S1, Salari F, Kashat L, Walfish PG. . J Clin Endocrinol Metab. 2015 May;100(5):1738-41 Immunotherapies against immune checkpoints that inhibit T cell activation [cytotoxic T lymphocyte antigen 4 (CTLA-4) and programmed cell death 1 (PD-1)] are emerging and promising […]

Read more »

RAI IMPROVES OUTCOME IN INTERMEDIATE RISK THYROID CANCER

Adjuvant radioactive iodine therapy is associated with improved survival for patients with intermediate-risk papillary thyroid cancer.Ruel E1, Thomas S, Dinan M, Perkins JM, Roman SA, Sosa JA. J Clin Endocrinol Metab. 2015 Apr;100(4):1529-36 Papillary thyroid cancer (PTC) is the most common endocrine malignancy. The long-term prognosis is generally excellent. Due to a paucity of data, […]

Read more »

MORE ON PROPHYLACTIC CENTRAL NODE DISSECTION

Prophylactic central compartment lymph node dissection in papillary thyroid carcinoma: clinical implications derived from the first prospective randomized controlled single institution study.Viola D1, Materazzi G, Valerio L, Molinaro E, Agate L, Faviana P, Seccia V, Sensi E, Romei C, Piaggi P, Torregrossa L, Sellari-Franceschini S, Basolo F, Vitti P, Elisei R, Miccoli P. J Clin […]

Read more »